WallStreetZenWallStreetZen

NASDAQ: MRTX
Mirati Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for MRTX

Based on 14 analysts offering 12 month price targets for Mirati Therapeutics Inc.
Min Forecast
$37.00-34.5%
Avg Forecast
$59.14+4.7%
Max Forecast
$82.00+45.16%

Should I buy or sell MRTX stock?

Based on 14 analysts offering ratings for Mirati Therapeutics Inc.
Buy
Strong Buy
4 analysts 28.57%
Buy
2 analysts 14.29%
Hold
8 analysts 57.14%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their MRTX stock forecasts and price targets.

MRTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-07
lockedlocked$00.00+00.00%2023-11-07
lockedlocked$00.00+00.00%2023-10-10
lockedlocked$00.00+00.00%2023-10-09
lockedlocked$00.00+00.00%2023-10-09
Jefferies
Bottom 2%
2
HoldDowngrades$58.00+2.67%2023-10-09
BMO Capital
Bottom 15%
15
HoldMaintains$72.00+27.46%2023-10-06
JMP Securities
Bottom 6%
6
BuyMaintains$82.00+45.16%2023-10-06
Citigroup
Top 18%
83
Strong BuyUpgrades$48.00-15.03%2023-08-10
Oppenheimer
Top 5%
96
BuyMaintains$62.00+9.75%2023-08-09

1 of 2

Forecast return on equity

Is MRTX forecast to generate an efficient return?
Company
N/A
Industry
-0.69%
Market
30.34%

Forecast return on assets

Is MRTX forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.29%

MRTX revenue forecast

What is MRTX's revenue in the next 3 years based on estimates from 8 analysts?
Avg 1 year Forecast
$64.1M+67.95%
Avg 2 year Forecast
$168.0M+339.78%
Avg 3 year Forecast
$268.2M+602.15%
MRTX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MRTX revenue growth forecast

How is MRTX forecast to perform vs Biotechnology companies and vs the US market?
Company
91.65%
Industry
34.65%
Market
7.68%
MRTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MRTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MRTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
MRTX$56.49$59.14+4.70%Buy
INSM$27.96$44.86+60.43%Strong Buy
MDGL$208.32$304.67+46.25%Buy
NUVL$70.66$60.50-14.38%Strong Buy
MLTX$55.40$75.38+36.06%Strong Buy
View Top Biotech Stocks

Mirati Therapeutics Stock Forecast FAQ

Is Mirati Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 14 Wall Street analysts covering (NASDAQ: MRTX) stock is to Buy MRTX stock.

Out of 14 analysts, 4 (28.57%) are recommending MRTX as a Strong Buy, 2 (14.29%) are recommending MRTX as a Buy, 8 (57.14%) are recommending MRTX as a Hold, 0 (0%) are recommending MRTX as a Sell, and 0 (0%) are recommending MRTX as a Strong Sell.

If you're new to stock investing, here's how to buy Mirati Therapeutics stock.

What is MRTX's revenue growth forecast for 2023-2025?

(NASDAQ: MRTX) Mirati Therapeutics's forecast annual revenue growth rate of 91.65% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.65%, and it is also forecast to beat the US market's average forecast revenue growth rate of 7.68%.

Mirati Therapeutics's revenue in 2023 is $38,191,000.On average, 8 Wall Street analysts forecast MRTX's revenue for 2023 to be $4,499,484,306, with the lowest MRTX revenue forecast at $3,767,563,142, and the highest MRTX revenue forecast at $5,695,993,727. On average, 8 Wall Street analysts forecast MRTX's revenue for 2024 to be $11,781,868,404, with the lowest MRTX revenue forecast at $8,270,414,537, and the highest MRTX revenue forecast at $16,744,257,422.

In 2025, MRTX is forecast to generate $18,810,598,398 in revenue, with the lowest revenue forecast at $15,056,503,616 and the highest revenue forecast at $27,500,706,660.

What is MRTX's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: MRTX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.29%.

What is MRTX's Price Target?

According to 14 Wall Street analysts that have issued a 1 year MRTX price target, the average MRTX price target is $59.14, with the highest MRTX stock price forecast at $82.00 and the lowest MRTX stock price forecast at $37.00.

On average, Wall Street analysts predict that Mirati Therapeutics's share price could reach $59.14 by Nov 7, 2024. The average Mirati Therapeutics stock price prediction forecasts a potential upside of 4.7% from the current MRTX share price of $56.49.

What is MRTX's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: MRTX) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.